Skip to content
2000
Volume 31, Issue 21
  • ISSN: 0929-8673
  • E-ISSN: 1875-533X

Abstract

The COVID-19 pandemic due to severe acute respiratory syndrome coronavirus 2 (SARS-COV-2) poses a major menace to economic and public health worldwide. Angiotensin-converting enzyme 2 (ACE2) and transmembrane protease serine 2 (TMPRSS2) are two host proteins that play an essential function in the entry of SARS-- COV-2 into host cells. Hydrogen sulfide (HS), a new gasotransmitter, has been shown to protect the lungs from potential damage through its anti-inflammatory, antioxidant, antiviral, and anti-aging effects. It is well known that HS is crucial in controlling the inflammatory reaction and the pro-inflammatory cytokine storm. Therefore, it has been suggested that some HS donors may help treat acute lung inflammation. Furthermore, recent research illuminates a number of mechanisms of action that may explain the antiviral properties of HS. Some early clinical findings indicate a negative correlation between endogenous HS concentrations and COVID-19 intensity. Therefore, reusing HS-releasing drugs could represent a curative option for COVID-19 therapy.

Loading

Article metrics loading...

/content/journals/cmc/10.2174/0929867330666230502111227
2024-06-01
2025-07-14
Loading full text...

Full text loading...

/content/journals/cmc/10.2174/0929867330666230502111227
Loading

  • Article Type:
    Review Article
Keyword(s): anti-inflammatory; anti-viral; coronavirus; COVID-19; cytokine storm; Hydrogen sulfide
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test